CINECA IRIS Institutional Research Information System

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

Yin Y;Pang M;Li Y;Rasenack J;Tanwandee T;Thongsawat S;Komolmit P;Gould M;George J;Sood A;Shah S;Piratvisuth T;Andreone P;Lee CM;Flisiak R;Sarin SK;Foster GR;Chuang WL;Zeuzem S;Pianko SCrawford D;Desmond P;George J;Pianko S;Sasadeusz J;Weltman M;Anderson F;Fournier C;Gould M;Swain M;Wong F;Yoshida E;Berg T;Buggisch P;Gerken G;Goeser T;Rasenack J;Zeuzem S;Habeeb A;Kapoor D;Kar P;Prabhakar B;Sarin S;Shah S;Sood A;Andreone P;Brunetto M;Craxi A;Mondelli M;Rizzetto M;Flisiak R;Jablkowski M;Andrade R;Barcena R;Buti M;Castellano D;Diago M;Perez R;Romero M;Sola R;Chang T;Chuang W;Kao J;Lee C;Komolmit P;Piratvisuth T;Sukeepaisarnjaroen W;Tanwandee T;Thongsawat S;Brown A;Cramp M;Foster GR;Mills P;Jacobson I;Bain V.

2012-01-01